Stock Analysis tagged as

Sector - Healthcare and Social Assistance

  • Showing 101-194 of 194 items
  • <<
  • 1
  • 2
  1. Overlooked Israel Is A Portfolio Growth Engine

  2. The Celtic Tiger Roars Once Again

  3. The REIT Play In Healthcare

  4. Valeant Eyes Bausch & Lomb

  5. Roche, Reloaded

  6. Elan Continues To Make Baffling Strategic Decision

  7. After A Big Rally, Pfizer Might Need Some Rest

  8. Adasuve Deal Is Very Good For Alexza, But What About Teva?

  9. Recent Financials May Not Be Entirely Fair To Hologic

  10. Amgen Chased By The Bubble

  11. Teva Still Too Cheap, But Still Too Uncertain

  12. It Gets A Little Harder From Here For Covidien

  13. Thermo Steps Up And Seals A Deal For Life Technologies

  14. Broad Weakness Makes It Harder To Like St. Jude Today

  15. Pharma Is Doing All The Pulling For Johnson & Johnson

  16. 4 ETFs To Play A Booming Healthcare Sector

  17. Pfizer Readies Zoetis For Market

  18. Herbalife Is Merely A Pawn In This Hedge Fund Battle Royal

  19. Should Third Quarter Results From Forest Laboratories Worry Investors?

  20. Abbott Labs Spins Off AbbVie: Which Is The Better Buy?

  21. A Look Back At The Year In Pharmaceuticals

  22. A Look Back At The Year In Medical Technology

  23. A Look Back At The Year In Biotech

  24. A Triple Play Of Biotech Disappointments Last Week

  25. How Far Can Philips' Turnaround Take The Stock?

  26. Smith & Nephew's Costly Deal

  27. Endo Health Solutions Needs Some Solutions Of Its Own

  28. Bayer Buys Schiff Nutrition International: Winners All Around

  29. Will It Be Even Harder For Life Tech To Muddle Through In 2013?

  30. Is “Less Bad” As Good As It Gets For Dendreon?

  31. Love Or Hate - Wall Street Will Love A Republican President

  32. Drugs Have Moved J&J On To A New Phase

  33. Washington Post Gets Into The Healthcare Business

  34. Danaher Does Another Typical Danaher Deal

  35. The Week In Healthcare

  36. Investor Unrest Leads The WellPoint CEO To Resign

  37. The Week Ahead In Healthcare

  38. The Week Ahead In Healthcare (August 20)

  39. Pfizer Looks To Spin Off Animal Health Unit

  40. The Week Ahead In Healthcare

  41. The Week Ahead In Healthcare

  42. More Healthy Alternatives To Zimmer

  43. The Week Ahead In Healthcare

  44. The Week Ahead In Healthcare

  45. The Week Ahead In Healthcare

  46. Hi-Tech Pharmacal An Under Followed Name Worth Following

  47. WellPoint Buys More Medicaid Exposure

  48. The Week Ahead In Healthcare

  49. Lincare Shows That You Can Go Home Again

  50. Healthcare Outlook For The Week Ahead

  51. Can Body Sculpting Bulk Up Solta Medical?

  52. Medicine Gets Personalized

  53. Bio-Reference Labs Taking Advantage Of Esoteric Opportunities

  54. Want A High-Yield Healthcare Stock? Look To Canada

  55. Stocks On Fire As The Market Bounces

  56. AmerisourceBergen Looks Very Healthy

  57. Lifepoint Hospitals Heads For The Country

  58. Becton Dickinson Safe And Steady

  59. Davita Goes Shopping

  60. Stocks That Keep You Looking Good

  61. The Trend In Rising Cancer Incidences

  62. Market-Crushing ETFs

  63. A Healthy Growth Strategy

  64. Control May Be Herbalife's Real Long-Term Problem

  65. Time To Buy Pharmaceuticals?

  66. Premium-Price athenahealth Leaves Little Room For Error

  67. CVS Caremark On A Healthy Upward Path

  68. Obagi Puts Its Problems Behind It

  69. Stocks Showing Resilience

  70. ilent Pays A Hefty Price For A Fixer-Upper Diagnostics Company

  71. Oversold Market Leads To Opportunities

  72. Treat Stocks Like Savings

  73. Top Rated Highly Shorted Stocks

  74. AstraZeneca Searches For Answers

  75. Amylin Puts Up 'For Sale' Sign

  76. LabCorp Fighting Industry Headwinds

  77. Will United Health's Cost Trends Cooperate?

  78. Glaxo Plays Hardball With Human Genome Sciences

  79. Buy Into Weakness

  80. 4 ETF's To Look At

  81. Healthcare Services Group - Great Business … Great Stock?

  82. Smart Stocks To Rally With

  83. A Strong Prognosis For Healthcare REITs

  84. Birth Control Subsidies Slashed: Will Big Pharma Take A Hit?

  85. Wall Street Isn't Buying The Medifast Story

  86. Stocks For An Uncertain World

  87. Value At Abbott Labs Balances A Lot Of Growth Optimism

  88. LabCorp Passes the Test

  89. Transcend Services: A Physician's Best Friend

  90. Pfizer Shrugs Off the Loss Of Lipitor

  91. Earnings The Doctor Ordered

  92. The Long-Term Play In Lab Work

  93. 4 Overbought Stocks To Watch

  94. Europe Won't Kill Siemens

  95. Bristol-Myers Pays Up To Patch A Gap

  96. Don't Count Out Healthcare Stocks

  97. Best S&P 500 Stocks Of 2011

  98. Top Income Plays For 2012

  99. Slow And Steady ETFs Outperforming

  100. 4 Heavily Shorted Stocks That Could Climb Higher

  • Showing 101-194 of 194 items
  • <<
  • 1
  • 2
Trading Center